Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Sep;40(3):397–402. doi: 10.1038/bjc.1979.194

Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.

G M Dusheiko, M C Kew, A R Rabson
PMCID: PMC2010032  PMID: 228691

Abstract

The value of the leucocyte adherence inhibition (LAI) test in the diagnosis of hepatocellular carcinoma (HCG) was investigated in 36 patients with this tumour. The sensitivity and specificity of the tube LAI test was assessed in 21 patients with HCC, 15 apparently healthy individuals, 9 patients with various forms of benign liver disease and 5 patients with non-hepatic neoplasms. In only 42% of the HCC patients tested was leucocyte adherence to glass reduced to a greater extent than in the healthy controls and in the patients with non-hepatic neoplasms, and the differences were not statistically significant. Moreover, positive results were obtained in 6/9 patients with benign hepatic disease. A further 15 patients were tested against extracts of HCC tissue using the haemacytometer LAI method. Of these, 53% gave positive results. In all, only 17/36 patients (47%) gave positive LAI responses. The test is thus of limited value in the diagnosis of HCC. The high false-negative result rate may be due either to abrogation of the immune response in HCC patients with large tumour burdens or to antigenic heterogeneity in HCC.

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bull D. M., Leibach J. R., Williams M. A., Helms R. A. Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration. Science. 1973 Sep 7;181(4103):957–959. doi: 10.1126/science.181.4103.957. [DOI] [PubMed] [Google Scholar]
  2. Grosser N., Thomson D. M. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Cancer Res. 1975 Sep;35(9):2571–2579. [PubMed] [Google Scholar]
  3. Halliday W. J., Halliday J. W., Campbell C. B., Maluish A. E., Powell L. W. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition. Br Med J. 1974 May 18;2(5915):349–352. doi: 10.1136/bmj.2.5915.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Halliday W. J., Miller S. Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors. Int J Cancer. 1972 May 15;9(3):477–483. doi: 10.1002/ijc.2910090304. [DOI] [PubMed] [Google Scholar]
  5. Howell J. H. Current status of leukocyte adherence inhibition. Cancer Res. 1979 Feb;39(2 Pt 2):556–557. [PubMed] [Google Scholar]
  6. Lee C., Chen S., Lin T. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma. Cancer Res. 1977 Mar;37(3):918–921. [PubMed] [Google Scholar]
  7. Leveson S. H., Howell J. H., Holyoke E. D., Goldrosen M. H. Leukocyte adherence inhibition: an automated microassay demonstrating specific antigen recognition and blocking activity in two murine tumor systems. J Immunol Methods. 1977;17(1-2):153–162. doi: 10.1016/0022-1759(77)90086-2. [DOI] [PubMed] [Google Scholar]
  8. Lopez M. J., O'Connor R., MacFarlane J. K., Thomson D. M. Clinical value of the tube leukocyte adherence inhibition assay in diagnosis and prognosis of breast cancer. Surg Forum. 1977;28:125–127. [PubMed] [Google Scholar]
  9. Maluish A. E. Experiences with leukocyte adherence inhibition in human cancer. Cancer Res. 1979 Feb;39(2 Pt 2):644–648. [PubMed] [Google Scholar]
  10. Maluish A., Halliday W. J. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test. J Natl Cancer Inst. 1974 May;52(5):1415–1420. doi: 10.1093/jnci/52.5.1415. [DOI] [PubMed] [Google Scholar]
  11. Murgita R. A., Tomasi T. B., Jr Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response. J Exp Med. 1975 Feb 1;141(2):269–286. doi: 10.1084/jem.141.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Connor R., MacFarlane J. K., Murray D., Thomson D. M. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. Br J Cancer. 1978 Dec;38(6):674–684. doi: 10.1038/bjc.1978.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rutherford J. C., Walters B. A., Cavaye G., Halliday W. J. A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer. Int J Cancer. 1977 Jan;19(1):43–48. doi: 10.1002/ijc.2910190107. [DOI] [PubMed] [Google Scholar]
  14. Shani A., Ritts R. E., Jr, Thynne G. S., Weiland L. H., Silvers A., Moertel C. G., Go V. L. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int J Cancer. 1978 Aug 15;22(2):113–119. doi: 10.1002/ijc.2910220202. [DOI] [PubMed] [Google Scholar]
  15. Tataryn D. N., MacFarlane J. K., Thomson D. M. Leucocyte adherence inhibition for detecting specific tumour immunity in early pancreatic cancer. Lancet. 1978 May 13;1(8072):1020–1022. doi: 10.1016/s0140-6736(78)90742-0. [DOI] [PubMed] [Google Scholar]
  16. Thomson D. M., Grosser N. Immunological mechanisms of tube leukocyte adherence inhibition. Cancer Res. 1979 Feb;39(2 Pt 2):576–581. [PubMed] [Google Scholar]
  17. Thomson D. M., Tataryn D. N., Lopez M., Schwartz R., MacFarlane J. K. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition. Cancer Res. 1979 Feb;39(2 Pt 2):638–643. [PubMed] [Google Scholar]
  18. Vánky F., Stjernswärd J., Klein G., Nilsonne U. Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors. J Natl Cancer Inst. 1971 Jul;47(1):95–103. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES